U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07889960) titled 'Development of a Cloud Platform for Advanced Diagnostics Based on Clinical and Omics Data.' on Oct. 12.
Brief Summary: This study aims to explore how information from different types of biological tests, such as genetic, protein, and fat-related analyses, can help doctors better identify and distinguish patients with systemic autoinflammatory diseases (SAIDs), including undifferentiated or complex forms of these conditions (uSAIDs and SAIDs), as well as fibromyalgia. The goal is to improve diagnosis and help identify the most appropriate treatments and care options for each patient.
The study will also develop computer-based tools ...